Stabilus SE announced that Annual General Meeting marked the end of Dr. Stephan Kessel?s term of office as a member and Chairman of the Supervisory Board of Stabilus SE. Dr. Kessel has played a key role in shaping the Supervisory Board for many years and has actively supported the strategic development of the Stabilus Group, including the IPO in 2014, in a phase of sustainable growth and far-reaching changes ? including periods as interim CEO .
The Annual General Meeting elected Dr. Frank Heinricht (63) as a new member of the Supervisory Board. Dr. Heinricht has more than three decades of experience in the metal, specialty glass and electrical industries and has held various management positions throughout his career. From 2013 to 2024, he was Chair of the Board of Management of Schott AG in Mainz, a technology group for the production of specialty glass and glass-ceramics, where he was responsible for the successful IPO of Schott Pharma AG in 2023.
Prior to that, he was a member of the Management Board of Heraeus Holding GmbH, a German family-owned technology group and one of Germany?s largest by revenue, from 2003 to 2013, most recently as Chair of the Management Board for six years. Dr. Heinricht also brings significant expertise from his advisory and supervisory board mandates. He has been Deputy Chair of the Advisory Board of the Würth Group for around 15 years.
In addition, he is a member of the Advisory Board of Schwarz Unternehmenstreuhand KG and a member of the Supervisory Board of B. Braun SE. Following the Annual General Meeting, the newly constituted Supervisory Board elected Dr. Frank Heinricht as Chairman of the Supervisory Board. He succeeds Dr. Stephan Kessel.
